)
Valtecne (VLT) investor relations material
Valtecne Q1 2026 TU earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Consolidated quarterly revenues surpassed €10 million for the first time, reaching €10.3 million as of March 31, 2026, up 9.6% year-over-year.
Growth was driven by the Medical business line, especially orthopaedic and dental segments, and a strong recovery in the Industrial business line.
Stand-alone revenues rose to €8.8 million, a 12.1% increase compared to the same period in 2025.
Financial highlights
Medical business line revenues grew 7.1% year-over-year to €7.5 million, maintaining about 75% of total consolidated revenues.
Industrial business line revenues increased 16.9% year-over-year to €2.7 million, reflecting market recovery.
Stand-alone Medical revenues rose 10.4% to €6.6 million; Industrial revenues up 17.3% to €2.2 million.
As of December 31, 2025, production value was €37.3 million and adjusted EBITDA was €9.7 million, with an EBITDA margin of 26.0%.
Outlook and guidance
Continued investments in digitalisation, production process innovation, and workforce expansion are planned to support growth.
Commercial development activities are being intensified to expand growth opportunities, leveraging new senior advisory expertise.
- Revenue fell 3.3% and net profit dropped 31%, but cash position and Medical segment strengthened.VLT
H2 20258 May 2026 - Medical Devices growth and improved margins drove stable H1 2024 results and strong cash for M&A.VLT
H1 20246 May 2026 - Medical segment now 75% of sales; EBITDA margin strong, debt up after acquisition.VLT
H1 20256 May 2026 - Medical segment drives 15.7% growth, now 68.3% of revenues; industrial down 21.9%.VLT
Q2 2024 TU13 Apr 2026 - Medical segment growth drove margin improvement and strong cash flow despite industrial headwinds.VLT
Investor presentation13 Apr 2026 - Medical segment growth offsets industrial decline, lifting nine-month revenue by 0.5%.VLT
Q3 2024 TU13 Apr 2026 - Medical revenues surged 15.1% in 2024, now comprising 70% of total sales.VLT
Q4 2024 TU13 Apr 2026 - Medical growth drives profitability and cash generation, with strategic expansion via Utilità S.r.l.VLT
Investor presentation13 Apr 2026 - Margins and net profit rose as medical devices drove growth; Utilità Srl acquisition completed.VLT
H2 202413 Apr 2026
Next Valtecne earnings date
Next Valtecne earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)